Mark your calendars for Thursday 31st October 2024, as Anika Therapeutics (NASDAQ: ANIK) is set to unveil its third quarter financial results. This highly anticipated announcement will be made before market open, giving investors and market participants a chance to assess the company's financial performance.
the organization is expected to report an estimated per share $0.01 loss for the quarter, as predicted by financial analysts on Wall Street. Furthermore, the company is anticipated to disclose a total revenue of $42.08 million during this period.
During the same quarter of the previous year, the company's earnings report indicated the total revenue has reached an impressive $41.47 million during that specific period.
Analysts forecasting the company's performance for this year have been made public. The estimated total revenue is about $170.22 million. They also predict that throughout the course of the fiscal year, the business will make about loss of $0.21 per share.
In addition, The firm will review the third quarter financial results on 31st October 2024 at 08:30 AM eastern time, in a conference call with public.
Anika Therapeutics (ANIK) experienced a trading range of $24.43 to $24.83, along with a total volume of 53.90 thousand shares during the day. The stock concluded Tuesday's regular trading session at $24.52, marking fall of 0.57 percent.
